Changes in brain-derived neurotrophic factor (BDNF) following treatment with mifepristone (RU-486) in bipolar disorder and schizophrenia

被引:0
|
作者
Mackin, P [1 ]
Gallagher, P [1 ]
Watson, S [1 ]
Ferrier, IN [1 ]
Young, AH [1 ]
机构
[1] Univ Newcastle Upon Tyne, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
481
引用
收藏
页码:132S / 133S
页数:2
相关论文
共 50 条
  • [1] Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia
    Mackin, Paul
    Gallagher, Peter
    Watson, Stuart
    Young, Allan H.
    Ferrier, I. Nicol
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2007, 41 (04): : 321 - 326
  • [2] Mifepristone (RU-486) in the treatment of bipolar disorder and schizophrenia
    Young, AH
    Watson, S
    Gallagher, P
    Smith, MS
    Del-Estal, D
    Owen, BM
    Hearn, A
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 143S - 143S
  • [3] Brain-derived neurotrophic factor (BDNF) and bipolar disorder
    Chiou Yu-Jie
    Huang Tiao-Lai
    PSYCHIATRY RESEARCH, 2019, 274 : 395 - 399
  • [4] Mifepristone (RU-486) in the treatment of schizophrenia
    Gallagher, P
    Smith, M
    Watson, S
    Owen, B
    Malik, N
    Mackin, P
    Ferrier, IN
    Young, AH
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 133S - 133S
  • [5] Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Schizophrenia and Bipolar Disorder: A Systematic Review
    Liberona, Andres
    Jones, Natalia
    Zuniga, Karen
    Garrido, Veronica
    Zelada, Mario Ignacio
    Silva, Hernan
    Nieto, Rodrigo R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [6] Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia
    Gallagher, Peter
    Watson, Stuart
    Dye, Cordelia Elizabeth
    Young, Allan H.
    Ferrier, I. Nicol
    JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 42 (12) : 1037 - 1041
  • [7] Improvements in Neurocognitive Function and Mood Following Adjunctive Treatment with Mifepristone (RU-486) in Bipolar Disorder
    Allan H Young
    Peter Gallagher
    Stuart Watson
    Dolores Del-Estal
    Bruce M Owen
    I Nicol Ferrier
    Neuropsychopharmacology, 2004, 29 : 1538 - 1545
  • [8] Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder
    Young, AH
    Gallagher, P
    Watson, S
    Del-Estal, D
    Owen, BM
    Ferrier, IN
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (08) : 1538 - 1545
  • [9] Efficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression
    Watson, Stuart
    Gallagher, Peter
    Porter, Richard J.
    Smith, Margaret
    Elmslie, Jane L.
    Ogilve, Aileen
    Harikumar, Thiyyancheri R.
    Menon, Anuradha
    Carlile, Jane
    Makhoul, Samer
    Ferrier, I. Nicol
    Young, Allan H.
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 135S - 136S
  • [10] Brain-Derived Neurotrophic Factor (BDNF) genetic pathway and bipolar disorder
    Toscano, E.
    Mandelli, L.
    Han, C.
    Lee, S.
    Patkar, A. A.
    Masand, P. S.
    Serretti, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S167 - S167